Objective: Our purpose was to investigate whether plasma lipid-soluble antioxidant levels during the third trimester of pregnancy and immediately after birth are altered in women with pregnancy-induced hypertension. Design: Nested case-control study of women with pregnancy-induced hypertension. Subjects: A group of 23 women with (mild) pregnancy-induced hypertension and their neonates, were compared with 23 matched controls with uncomplicated pregnancies. Methods: Concentrations of vitamin E isomers, several carotenoids, and retinol were determined by HPLC in venous plasma which had been stored for 2 ± 5 y. Antioxidant levels were adjusted for the degree of fatty acid unsaturation in plasma phospholipids as analysed 2 ± 5 y before. Results: In the third trimester of pregnancy, lipid-soluble antioxidant levels were similar in women with pregnancy-induced hypertension and controls. From the third trimester to postpartum, mean (AEs.e.m.) b gtocopherol levels decreased by 0.38AE0.17 mmolal or 5% (P 0.038) in the control group. In the pregnancyinduced hypertension group, however, plasma levels of most antioxidants decreased from the third trimester to postpartum, but only the decreases in plasma levels of b g-tocopherol of 1.08AE0.27 mmolal or 26% (P 0.042), of a-tocopherol of 2.51AE1.58 mmolal or 6% (P 0.024), and of lutein of 0.13AE0.04 mmolal or 15% (P 0.013) reached statistical signi®cance as compared with the changes in the control group. At the same time, the polyunsaturated fatty acid unsaturation index of plasma phospholipids (UI) decreased in the pregnancyinduced hypertension group as well. Consequently, antioxidant levels, adjusted for UI, changed similarly in both groups. Umbilical vein plasma antioxidant levels were also similar after complicated and uncomplicated pregnancies. Conclusion: Plasma lipid-soluble antioxidant levels in mother and child are affected by mild pregnancy-induced hypertension, but this effect disappears after adjustment for fatty acid unsaturation.
Introduction
Recently, it has been suggested that many of the clinical and pathophysiological features of pregnancy-induced hypertension might be explained by an imbalance between lipid peroxidation and antioxidant status (Hubel et al, 1989; Walsh, 1994) . Especially the role of the lipid-soluble antioxidants, like vitamin E, was emphasized (Walsh, 1994) . Indeed, during the third trimester of pregnancy, plasma vitamin E levels were signi®cantly lower in women with severe pregnancy-induced hypertension, as compared with uncomplicated pregnancies (Wang et al, 1991) . However, Uotila et al (1993a) reported increased, rather than decreased, plasma vitamin E levels and total peroxyl radical-trapping capacity (TRAP; Uotila et al, 1994) during severe pregnancy-induced hypertension. After delivery, plasma vitamin E levels were found to be similar in women with and without pregnancy-induced hypertension (Uotila et al, 1993b) , as were plasma levels of the newborns in both groups (Uotila et al, 1993b; von Mandach et al, 1993) . Reports on other lipid-soluble antioxidants in pregnancies complicated with pregnancyinduced hypertension are scarce and also inconclusive (Uotila et al, 1993b; Mikhail et al, 1994) . These inconsistent results indicate that more antioxidants may have to be included in the evaluation of the antioxidant status in women with pregnancy-induced hypertension.
Therefore, we have studied plasma levels of three vitamin E isomers, several carotenoids, and retinol in women with pregnancy-induced hypertension and their neonates. Since a major action of these lipid-soluble antioxidants involves protection of polyunsaturated fatty acids, antioxidant levels were also adjusted for the degree of fatty acid unsaturation of plasma phospholipids. In this respect, it is also important to note that changes in the amount of the peroxidation-susceptible polyunsaturated fatty acids from the third trimester to postpartum are different in women with and without pregnancy-induced hypertension (Al et al, 1995) .
Methods

Samples and design
Venous plasma samples, anticoagulated with ethylenediaminetetraacetic acid, were obtained from a large study investigating the essential fatty acid status of mother and child in pregnancy-induced hypertension (Al et al, 1995) . Lipid-soluble antioxidant levels during the third trimester and postpartum were determined in plasmas from 23 women with pregnancy-induced hypertension and 23 women with uncomplicated pregnancies (controls). Venous cord plasma samples of their neonates were analysed as well. Based on the results of our previous study (Oostenbrug et al, 1998) it was calculated before the start of the study thatÐat a power of 80%Ða difference of 8% for plasma polyunsaturated fatty acid-standardized total tocopherol levels and of 15 ± 30% for the various carotenoids could be detected with 23 subjects in each group. Third trimester samples had been collected at approximately 32 weeks of gestation, postpartum maternal samples within 24 h after delivery, and cord samples within 2 h after parturition. At entry for the study, which was before week 16 of gestation, all women had a diastolic blood pressure (DBP)`90 mm Hg, and did not suffer from cardiovascular, neurological, renal or metabolic disorders. Women with a DBP of ! 90 mm Hg on two consecutive measurements ! 4 h apart, one measurement of ! 110 mm Hg after 20 weeks of gestation, or an increase of ! 25 mm Hg during pregnancy, were classi®ed as patients with pregnancyinduced hypertension (Davey & MacGillivray, 1988) .
Each woman with pregnancy-induced hypertension was matched with a control for parity and hospital, and was usually delivered in the same week as her control. Only women who intended to deliver at the hospital, and had singleton pregnancies were included. Three hospitals, within a radius of 15 miles, participated in this study. Informed consent was received from each participant, and prior approval for the study was obtained from the Medical Ethics Committee of the University.
Plasma antioxidant analysis
Until antioxidant analysis, plasma samples had been stored in the frozen state for 2 ± 5 y at À80 C. A pilot study has shown that the concentration of the reported antioxidants is stable in plasma stored for 5 y at À80 C (Oostenbrug, 1996) . Plasma was analysed by HPLC for the vitamin E isomers, d-tocopherol, b g-tocopherol and a-tocopherol, for the carotenoids, lutein, lycopene, a-carotene, b-carotene and phyto¯uene, and for retinol (Hess et al, 1991; Oostenbrug et al, 1997) . All samples from one subject, her neonate, and the samples from the matched control were analysed in the same analytical run. Since pure phyto¯uene was not available, quantitative determination of this compound was not possible. Between-run coef®cients of variation for a mixture of standards ranged from 1.1 ± 2.2% for the various antioxidants. The mean (AEs.e.m.) recovery of the internal standard retinyl acetate added to plasmas was 97AE0.5%, and the detection limit in plasma samples was 0.003 mmolal for all antioxidants.
Plasma phospholipid fatty acid analysis Details of the plasma phospholipid fatty acid analysis have been reported before (Al et al, 1995) . Brie¯y, lipids were extracted from plasma using a modi®ed Folch method, and the phospholipids were separated on aminopropyl-bonded silica columns. The phospholipid fatty acids were then transmethylated to the corresponding methylesters, which were quanti®ed on a non-polar capillary column. Fatty acid unsaturation was estimated by calculating the polyene unsaturation index (UI) as the sum of the millimolar concentration of each polyunsaturated fatty acid (polyene) in the phospholipids multiplied with its number of double bonds.
Statistical analysis
Paired Student's t-tests were used to compare clinical parameters and plasma values during the third trimester in the pregnancy-induced hypertension group with those in the control group. Then, changes from the third trimester to postpartum were evaluated by paired t-tests, as previous research showed a signi®cant decrease in phospholipid polyunsaturated fatty acid levels during this period in women with pregnancy-induced hypertension (Al et al, 1995) . Postpartum maternal and neonatal values were also compared by Student's t-tests. Unpaired Student's ttests were used to compare plasma values in hypertensive women with proteinuria with those without proteinuria. Pearson's correlation coef®cients were calculated between DBP and plasma antioxidant levels. The level of signi®-cance was set at P`0.05. Values are reported as means AE s.e.m. All statistical analyses were performed using the Statistical Analysis System, SAS 6.09 (1989 ± 1992) .
Results
Clinical characteristics
In the control group, aged 29.2AE0.9 y, the mean DBP at entry was 67.0AE1.6 mm Hg, while seven women smoked. In the pregnancy-induced hypertension group, aged 28.0AE0.6 y (P 0.257 vs controls), the DBP at entry was 72.0AE1.7 mm Hg (P 0.026 vs controls), while three women smoked. In both groups, 19 women were nulliparae at entry, and four women gave birth to their second baby. During pregnancy, the mean maximum DBP in the control group was 75.3AE0.8 mm Hg, and in the pregnancy-induced hypertension group 99.8AE1.7 mm Hg (P`0.0001 vs controls). In the latter group, eight women developed proteinuria during pregnancy. In the control group, 10 male and 13 female infants were born with an average birthweight of 3285AE99 g, and in the pregnancy-induced hypertension group, 14 male and 9 female infants who weighed on average 2969AE153 g (P 0.046 vs controls). The women were delivered at similar gestational ages, after 278.7AE1.5 d for the controls, and after 274.8AE3.3 d for the patients (P 0.243 vs controls). In both groups, one woman was delivered by cesarean section.
Maternal plasma antioxidant levels and phospholipid fatty acid composition
In the third trimester of pregnancy, plasma antioxidant levels were similar in the pregnancy-induced hypertension and control group (Table 1 ). In the control group, only b g-tocopherol levels changed signi®cantly from the third trimester to postpartum. Mean levels decreased by 0.38AE0.17 mmolal (P 0.038) or 5%. In the pregnancyinduced hypertension group, however, a signi®cant decrease of 3.66AE1.64 mmolal (P 0.036) or 8% was noticed for plasma levels of total tocopherol, whereas d-tocopherol, b g-tocopherol, total carotenoid, lutein, a-carotene, and b-carotene levels decreased by more than 15% (P`0.02). The average decrease in lycopene of 0.124AE0.061 mmolal or 16%, was of borderline signi®-cance (P 0.052). The decreases in total tocopherol, b gtocopherol, total carotenoid, and lutein levels in the pregnancy-induced hypertension group were signi®cantly Pregnancy-induced hypertension CS Oostenbrug et al different from the changes in the control group (P 0.015, P 0.042, P 0.025, and P 0.013, vs controls, respectively). Although the changes in a-tocopherol levels within each group did not reach statistical signi®cance, the decrease in the pregnancy-induced hypertension group was signi®cantly different from the increase in the control group (P 0.024). No signi®cant correlations were found between antioxidant levels and DBP, or between changes in these parameters from the third trimester to postpartum.
Mean phospholipid fatty acid levels during the third trimester were similar in the pregnancy-induced hypertension and control group (Table 2) . From the third trimester to postpartum, phospholipid fatty acid levels in the control group slightly increased, whereas for some fatty acids, plasma phospholipid levels decreased in the pregnancyinduced hypertension group. Signi®cant differences between the change in the control group and change in the pregnancy-induced hypertension group were noticed for phospholipid total fatty acid levels (P 0.028), saturated fatty acid levels (P 0.036), polyene levels (P 0.007), n-6 polyene levels (P 0.009), and linoleic acid levels (P 0.004). From the third trimester to postpartum, the polyene unsaturation index (UI) increased by 5% in the control group (P 0.061), and decreased by 5% in the pregnancy-induced hypertension group (P 0.245). These changes were signi®cantly different between the two groups (P 0.014).
From the third trimester to postpartum, ratios of b gtocopherol and lycopene to UI decreased by 9% (P 0.010 and P 0.044, respectively) in the control group (Table 3) . In the pregnancy-induced hypertension group, d-tocopherolaUI ratios decreased by 17% (P 0.023), b g-tocopherolaUI by 23% (P 0.001), luteinaUI by 11% (P 0.022), and b-caroteneaUI by 9% (P 0.046). However, these decreases did not signi®cantly differ from the changes in the control group (Table 3) .
In the pregnancy-induced hypertension group there were no signi®cant differences in fatty acid or antioxidant levels between women with or without proteinuria, except for a slightly higher (P 0.027) oleic acid content in phospholipids during the third trimester in women with proteinuria.
Neonatal plasma antioxidant levels and phospholipid fatty acid composition All umbilical vein plasma tocopherols and carotenoids levels were signi®cantly lower than concurrent maternal postpartum levels, and mean cordamaternal ratios varied from 8% for lycopene to 31% for d-tocopherol levels (Table 4 ). Mean cord plasma retinol levels were also signi®cantly lower than maternal levels (P`0.0001), but the cordamaternal ratios (mean: 67.8AE5.6%, n 46) ranged from 25 ± 225%. However, no signi®cant differences in cord plasma antioxidant levels between the control group and pregnancy-induced hypertension group were noticed. Although most mean cordamaternal ratios were higher in the pregnancy-induced hypertension group, only the higher ratio for b g-tocopherol (25%) reached statistical signi®cance (P 0.030) as compared with the ratio in the control group (18%). Total, saturated, monounsaturated, and n-6 polyunsaturated fatty acid levels in cord plasma phospholipids were similar after pregnancies complicated with pregnancyinduced hypertension and uncomplicated pregnancies (results not shown). Cord plasma n-3 polyunsaturated fatty acid levels in phospholipids were signi®cantly higher after pregnancy-induced hypertension (P 0.005), mainly due to higher docosahexaenoic acid (C22:6 n-3) levels (P 0.006). However, the UI was similar in cord plasma from the pregnancy-induced hypertension (2891AE110) and control group (2689AE156; P 0.212 between groups). Total tocopherolaUI and total carotenoidaUI ratios in the patient group were 2.702AE0.126 (P 0.922 vs controls) and 0.070AE0.005 (P 0.449 vs controls), respectively, whereas the ratios in the control group were 2.685AE0.119 and 0.078AE0.010, respectively. AntioxidantaUI ratios for the separate antioxidants were also similar in both groups.
Discussion
Reports on plasma lipid-soluble antioxidant levels in pregnancies complicated with pregnancy-induced hypertension are inconclusive, and usually limited to information about vitamin E levels (see introduction). To evaluate the antioxidant status in women with pregnancy-induced hypertension more extensively, we have examined plasma levels of nine lipid-soluble antioxidants during the third trimester and postpartum, and have compared these levels with levels in women without pregnancy-induced hypertension. In addition, umbilical vein plasma levels in concurrent neonates were studied.
Mean third trimester maternal plasma antioxidant levels were not signi®cantly different between the pregnancyinduced hypertension group and controls. Comparable Table 3 Ratio of plasma lipid-soluble antioxidant levels to phospholipid polyunsaturated fatty acid index in women with uncomplicated pregnancies (control group) and in women with pregnancies complicated with pregnancy-induced hypertension
Control group (n 23)
Pregnancy-induced hypertension group (n 23) Tables 1 and 2 ). * , **Signi®cant difference within group, paired Student's t-test: *P`0.05; **P`0.01. Values are meansAEs.e.m., and are expressed in mmolal. Phyto¯uene levels are reported as chromatogram peak areas (mV6minaml plasma, ampli®cation 100). *All cord plasma antioxidant levels were signi®cantly lower than maternal levels, paired Student's t-test: P`0.001. {Signi®cant difference between groups, paired Student's t-test: P`0.05. }C/M% expresses the average ratio (6 100%) of cord vs postpartum maternal levels (see also Table 1 ). §Cord plasma levels of phyto¯uene are given as ranges, since only small traces were detected, in 11 control and 7 patient cord samples.
Pregnancy-induced hypertension CS Oostenbrug et al vitamin E (total tocopherol) levels in women with mild pregnancy-induced hypertension, as compared with controls, were also reported by others (Wang et al, 1991; Uotila et al, 1993a) . In women with severe pregnancyinduced hypertension, however, decreased (Wang et al, 1991) as well as increased (Uotila et al, 1993a) plasma vitamin E levels have been reported. Power analysis showed that the number of subjects in the present study was suf®cient to detect differences as reported in these latter studies (Wang et al, 1991; Uotila et al, 1993a) . However, in our study, only 4 out of 23 women with pregnancy-induced hypertension had a maximum DBP of 110 mm Hg or more, one of the criteria for severe pregnancy-induced hypertension in those studies (Wang et al, 1991; Uotila et al, 1993a) . Data from a study of Gu Èlme-zoglu et al, (1997) have suggested that lipid peroxidation increases with the severity of the disease, although this raise may be hardly detectable between our cases with predominantly mild hypertension and our controls (Uotila et al, 1993a) . Variations in the severity of hypertension may, therefore, explain the difference in results between the present study and the earlier studies (Wang et al, 1991; Uotila et al, 1993a) . It remains, however, to be determined whether vitamin E levels are changed in women with a severe degree of pregnancy-induced hypertension, but not in women with mild pregnancy-induced hypertension. Our study also showed no difference in plasma levels of various other lipid-soluble antioxidants during the third trimester between women with or without pregnancy-induced hypertension, which has also been reported for b-carotene (Mikhail et al, 1994) . b g-Tocopherol, a-tocopherol, lutein, total tocopherol, and total carotenoid levels decreased from the third trimester to postpartum in the pregnancy-induced hypertension group, as compared with the changes in the control group. However, at the same time, the concentration of peroxidation-susceptible polyunsaturated fatty acids in phospholipids, and thus the UI, were also decreased, as compared with the control group. Within the pregnancy-induced hypertension group, antioxidantsaUI ratios for several antioxidants still decreased signi®cantly from the third trimester to postpartum, but these decreases were not signi®cantly different from changes in the control group.
In both groups, b g-tocopherol levels and b g-tocopherolaUI ratios decreased signi®cantly from the third trimester to postpartum, and in the pregnancy-induced hypertension group, the respective values for d-tocopherol as well. Although this may be a result of (oxidative) stress during labour, the period between third trimester sampling and parturition is too long to substantiate this. Furthermore, the reason why only the less abundant tocopherol isomers decrease from the third trimester to postpartum, and levels of other lipid-soluble antioxidants do not, is unclear. However, in patients undergoing percutaneous transluminal coronary angioplasty, a medical procedure associated with oxidative stress, we also noticed a decrease in the concentrations of d-tocopherol and b g-tocopherol in low density lipoproteins, two days after the procedure, but no decrease in a-tocopherol concentrations (Oostenbrug et al, 1997) .
Results from the present study do not indicate that the status of lipid-soluble antioxidants in the neonate is affected by pregnancy-induced hypertension in the mother, since cord plasma antioxidant levels and antioxidantaUI ratios in both groups were similar. Only a few other studies have investigated neonatal plasma antioxidant levels after pregnancies complicated with pregnancy-induced hypertension. In agreement with our ®ndings, neonatal plasma vitamin E levels have been found to be unaffected by maternal pregnancy-induced hypertension (Uotila et al, 1993b; von Mandach et al, 1993) . Uotila et al (1993b) , however, have found lower cord plasma retinol levels after pregnancies complicated with severe pregnancy-induced hypertension.
This study has focussed on lipid-soluble antioxidants, since protection of the lipophilic membranes may play a role in the pathogenesis of pregnancy-induced hypertension (see introduction). However, water-soluble antioxidants may be important as well. For example, vitamin C has a sparing effect on vitamin E by regenerating the oxidized form (Niki, 1987) . Although Mikhail et al (1994) found decreased plasma levels of vitamin C during the third trimester in women with pregnancy-induced hypertension, Uotila et al (1994) reported similar levels just before delivery in women with and without pregnancy-induced hypertension. In women with pregnancy-induced hypertension, Uotila et al (1994) also found increased plasma levels of uric acid and unidenti®ed antioxidants, both contributing to higher TRAP values.
Conclusion
This study showed that maternal plasma lipid-soluble antioxidant levels during the third trimester are similar in pregnancies complicated with mild pregnancy-induced hypertension and uncomplicated pregnancies. Although from the third trimester to postpartum plasma levels of several antioxidants decrease in women with pregnancyinduced hypertension, the UI decreases as well. Consequently, the antioxidantaUI ratios change similarly in women with and without mild pregnancy-induced hypertension. Neonatal lipid-soluble antioxidant levels in plasma are also not affected by maternal mild pregnancy-induced hypertension. Possibly, a future study with more cases of severe pregnancy-induced hypertension may show whether the slight, but non-signi®cant, decreases in maternal antioxidantaUI ratios from the third trimester to postpartum depend on the severity of pregnancy-induced hypertension. Intervention studies, however, are needed to show the clinical importance of antioxidants in pregnancy-induced hypertension.
